Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
127.5 GBX | 0.00% | +6.25% | -58.20% |
Apr. 16 | Faron Pharmaceuticals Oy Confirms Plans for the Coming Months | CI |
Apr. 15 | Faron Pharmaceuticals reappoints former finance chief on interim basis | AN |
Sales 2024 * | 14.4M 15.44M | Sales 2025 * | 39.09M 41.92M | Capitalization | 107M 115M |
---|---|---|---|---|---|
Net income 2024 * | -6M -6.44M | Net income 2025 * | -4M -4.29M | EV / Sales 2024 * | 9.54 x |
Net Debt 2024 * | 30.6M 32.82M | Net cash position 2025 * | 42.27M 45.33M | EV / Sales 2025 * | 1.65 x |
P/E ratio 2024 * |
-4.84
x | P/E ratio 2025 * |
-9.57
x | Employees | 34 |
Yield 2024 * |
1.01% | Yield 2025 * |
-
| Free-Float | 60.17% |
Latest transcript on Faron Pharmaceuticals Oy
1 week | +6.25% | ||
Current month | -7.27% | ||
1 month | -12.07% | ||
3 months | -56.03% | ||
6 months | -57.50% | ||
Current year | -58.20% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | - | 02-12-31 | |
Founder | 46 | 02-12-31 | |
Founder | 70 | 02-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | 70 | 02-12-31 | |
Chairman | 60 | 23-03-23 | |
Founder | 46 | 02-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 127.5 | 0.00% | 22,023 |
24-04-23 | 127.5 | +6.25% | 1,464 |
24-04-22 | 120 | +2.13% | 29,914 |
24-04-19 | 117.5 | -0.42% | 4,573 |
24-04-18 | 118 | -1.67% | 51,043 |
Delayed Quote London S.E., April 24, 2024 at 11:35 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-58.20% | 114M | |
-1.51% | 104B | |
+3.22% | 97.42B | |
+1.86% | 22.2B | |
-16.53% | 21.23B | |
-8.49% | 18.33B | |
-42.33% | 16.35B | |
-20.09% | 15.06B | |
+5.47% | 13.98B | |
+28.85% | 11.66B |
- Stock Market
- Equities
- FARN Stock